Evidence map›Paper›PMID 41567191›Full record

ArticleFrontiers in immunology2025

Jin-Sil Park, Hye Yeon Kang, JeongWon Choi, Wonjong Lee, Hyunbin Seong, Sang Hee Cho, Su Beom Lee, Nam Soo Han, Jaekwon Choi, Bo-In Lee and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jin-Sil ParkRheumatism Research Center, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Hye Yeon KangLab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
JeongWon ChoiLab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Wonjong LeeCentral Research Institute, Dr. Chung's Food Co. Ltd., Cheongju, Republic of Korea.
Hyunbin SeongBrain Korea 21 Center for Smart GreenBio Convergence and Sustainable Regional Development, Division of Animal, Horticultural, Food Sciences, Chungbuk National University, Cheongju, Republic of Korea.
Sang Hee ChoLab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Su Beom LeeLab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Nam Soo HanBrain Korea 21 Center for Smart GreenBio Convergence and Sustainable Regional Development, Division of Animal, Horticultural, Food Sciences, Chungbuk National University, Cheongju, Republic of Korea.
Jaekwon ChoiCentral Research Institute, Dr. Chung's Food Co. Ltd., Cheongju, Republic of Korea.
Bo-In LeeDivisions of Gastroenterology and Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Mi-La ChoLab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Given that microbiota dysbiosis is closely linked to the initiation and progression of inflammatory bowel disease (IBD), extensive research is underway to utilize beneficial probiotics as a therapeutic strategy for IBD. In this study, we compared the therapeutic efficacy of Methods: Live Results: Treatment with Conclusion: Our findings suggest that

Indexed as

ColitisDysbiosisGastrointestinal MicrobiomeGlycine maxProbioticsAnimalsCytokinesDextran SulfateDisease Models, AnimalFibrosisMaleMiceSeverity of Illness IndexCytokinesDextran Sulfatefibrosisgut microbiotainflammationinflammatory bowel diseaseLatilactobacillus curvatuspostbiotics

Identifiers

PMID41567191
PMCPMC12815751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.